| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Androgens and prostate cancer: Biology, pathology and hormonal therapy
|
Galbraith, S.M.
|
|
1997
|
33 |
4 |
p. 545-554
10 p.
|
artikel
|
| 2 |
Announcement
|
|
|
1997
|
33 |
4 |
p. 608-
1 p.
|
artikel
|
| 3 |
A phase I–II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer
|
Bolis, G.
|
|
1997
|
33 |
4 |
p. 592-595
4 p.
|
artikel
|
| 4 |
Arbiter:
|
Harris, M.
|
|
1997
|
33 |
4 |
p. 524-525
2 p.
|
artikel
|
| 5 |
Attributable risks for hepatocellular carcinoma in Northern Italy
|
Braga, C.
|
|
1997
|
33 |
4 |
p. 629-634
6 p.
|
artikel
|
| 6 |
BRCA1 mutations found in archived early onset breast tumours
|
Garvin, A.M.
|
|
1997
|
33 |
4 |
p. 683-686
4 p.
|
artikel
|
| 7 |
Calendar of forthcoming meetings
|
|
|
1997
|
33 |
4 |
p. I-IV
nvt p.
|
artikel
|
| 8 |
Cathepsin D content in malignant tumours of corpus uteri
|
Osmak, M.
|
|
1997
|
33 |
4 |
p. 699-700
2 p.
|
artikel
|
| 9 |
Childhood cancer incidence in Zaragoza and Navarre (Spain): 1973–1987
|
Pollán, M.
|
|
1997
|
33 |
4 |
p. 616-623
8 p.
|
artikel
|
| 10 |
Childhood leukaemia and radiation
|
|
|
1997
|
33 |
4 |
p. 513-
1 p.
|
artikel
|
| 11 |
Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/ leucovorin in advanced pancreatic adenocarcinoma
|
Raymond, E.
|
|
1997
|
33 |
4 |
p. 696-697
2 p.
|
artikel
|
| 12 |
Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42
|
Moran, E.
|
|
1997
|
33 |
4 |
p. 652-660
9 p.
|
artikel
|
| 13 |
Colon dose of iodine-131 higher than estimates after use for thyroif cancer
|
|
|
1997
|
33 |
4 |
p. 515-
1 p.
|
artikel
|
| 14 |
Colorectal cancer—Is there an alternative to 5-FU?
|
Bleiberg, H.
|
|
1997
|
33 |
4 |
p. 536-541
6 p.
|
artikel
|
| 15 |
Contra:
|
Mooi, W.J.
|
|
1997
|
33 |
4 |
p. 523-524
2 p.
|
artikel
|
| 16 |
Correction and apology
|
|
|
1997
|
33 |
4 |
p. 701-
1 p.
|
artikel
|
| 17 |
Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens
|
Bajetta, E.
|
|
1997
|
33 |
4 |
p. 687-690
4 p.
|
artikel
|
| 18 |
ECF treatment doubles survival chances for gastric cancer patients
|
|
|
1997
|
33 |
4 |
p. 514-
1 p.
|
artikel
|
| 19 |
EMEA boast 36 products in 26 months
|
|
|
1997
|
33 |
4 |
p. 512-513
2 p.
|
artikel
|
| 20 |
Endothelin expression and responsiveness in human ovarian carcinoma cell lines
|
Moraitis, S.
|
|
1997
|
33 |
4 |
p. 661-668
8 p.
|
artikel
|
| 21 |
EORTC fellow profiles: Dr Susan Keating, MD
|
|
|
1997
|
33 |
4 |
p. 513-
1 p.
|
artikel
|
| 22 |
Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer
|
Raghavan, D.
|
|
1997
|
33 |
4 |
p. 566-574
9 p.
|
artikel
|
| 23 |
Fight against cancer in countries with limited resources
|
|
|
1997
|
33 |
4 |
p. 511-
1 p.
|
artikel
|
| 24 |
Homeobox genes: Molecular link between congenital anomalies and cancer
|
Anbazhagan, R.
|
|
1997
|
33 |
4 |
p. 635-637
3 p.
|
artikel
|
| 25 |
Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis
|
Monte, M.
|
|
1997
|
33 |
4 |
p. 676-682
7 p.
|
artikel
|
| 26 |
Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas
|
Kaaijk, P.
|
|
1997
|
33 |
4 |
p. 645-651
7 p.
|
artikel
|
| 27 |
Inhibition of telomerase activity by cisplatin in human testicular cancer cells
|
Burger, A.M.
|
|
1997
|
33 |
4 |
p. 638-644
7 p.
|
artikel
|
| 28 |
Mammographic screening for breast cancer. What cancers do we find?
|
Norden, T.
|
|
1997
|
33 |
4 |
p. 624-628
5 p.
|
artikel
|
| 29 |
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients
|
Mantovani, G.
|
|
1997
|
33 |
4 |
p. 602-607
6 p.
|
artikel
|
| 30 |
Mitotic percentage index: a new prognostic factor for childhood medulloblastoma
|
Gilbertson, R.J.
|
|
1997
|
33 |
4 |
p. 609-615
7 p.
|
artikel
|
| 31 |
Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells
|
Marverti, G.
|
|
1997
|
33 |
4 |
p. 669-675
7 p.
|
artikel
|
| 32 |
No overall risk breast cancer with induced abortions
|
|
|
1997
|
33 |
4 |
p. 514-
1 p.
|
artikel
|
| 33 |
Prevention and early detection of colorectal cancer
|
Inauen, W.
|
|
1997
|
33 |
4 |
p. 694-
1 p.
|
artikel
|
| 34 |
Pro:
|
Daugaard, S.
|
|
1997
|
33 |
4 |
p. 521-522
2 p.
|
artikel
|
| 35 |
Professor Peter Selby now director of clinical research for imperial cancer research fund
|
|
|
1997
|
33 |
4 |
p. 516-
1 p.
|
artikel
|
| 36 |
Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
|
Volm, M.
|
|
1997
|
33 |
4 |
p. 691-693
3 p.
|
artikel
|
| 37 |
Progress in the management of T3-4 adenocarcinoma of the prostate
|
Zietman, A.L.
|
|
1997
|
33 |
4 |
p. 555-559
5 p.
|
artikel
|
| 38 |
Radiation-recall dermatitis with docetaxel: Establishment of a requisite radiation threshold
|
Yeo, W.
|
|
1997
|
33 |
4 |
p. 698-699
2 p.
|
artikel
|
| 39 |
Radiotherapy-induced second cancers: Are we doing enough to protect young patients?
|
Epstein, R.
|
|
1997
|
33 |
4 |
p. 526-530
5 p.
|
artikel
|
| 40 |
Report on 8th World Congress on pain, 17–22 August 1996
|
Pereira, J.
|
|
1997
|
33 |
4 |
p. 542-543
2 p.
|
artikel
|
| 41 |
Rhabdomyolysis and renal function impairment after isolated limb perfusion—Comparison between the effects of perfusion with rhTNFα and a ‘triple-drug’ regimen
|
Hohenberger, P.
|
|
1997
|
33 |
4 |
p. 596-601
6 p.
|
artikel
|
| 42 |
Role of radical prostatectomy in micrometastases dissemination
|
Sardi, I.
|
|
1997
|
33 |
4 |
p. 694-695
2 p.
|
artikel
|
| 43 |
S-phase fractions of breast cancer predict overall and post-relapse survival
|
Remvikos, Y.
|
|
1997
|
33 |
4 |
p. 581-586
6 p.
|
artikel
|
| 44 |
The assessment of treatment outcomes in metastatic prostate cancer: Changing endpoints
|
Dawson, N.A
|
|
1997
|
33 |
4 |
p. 560-565
6 p.
|
artikel
|
| 45 |
The minimal effective exemestane dose for endocrine activity in advanced breast cancer
|
Bajetta, E.
|
|
1997
|
33 |
4 |
p. 587-591
5 p.
|
artikel
|
| 46 |
The usefulness of screening data for studying the biology of breast cancer
|
van Dongen, J.A.
|
|
1997
|
33 |
4 |
p. 519-520
2 p.
|
artikel
|
| 47 |
Thymus therapy for cancer
|
Cassileth, B.R.
|
|
1997
|
33 |
4 |
p. 517-518
2 p.
|
artikel
|
| 48 |
Thymus therapy for cancer? A criteria-based, systematic review
|
Ernst, E.
|
|
1997
|
33 |
4 |
p. 531-535
5 p.
|
artikel
|
| 49 |
U.K. group to explore the use of biological markers in cancer
|
|
|
1997
|
33 |
4 |
p. 515-
1 p.
|
artikel
|
| 50 |
Uterine cervival cancer has major risk factors in common with the smoking cancers
|
|
|
1997
|
33 |
4 |
p. 514-515
2 p.
|
artikel
|
| 51 |
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway
|
Risberg, T.
|
|
1997
|
33 |
4 |
p. 575-580
6 p.
|
artikel
|
Tijdschrift beschrijving